Product
Help
Pricing
About
Jobs
Log in
Get started
Institution
Add to collection
Osaka Habikino Medical Center
Homepage:
ra.opho.jp
Alternate names:
Osaka Prefectural Medical Center for Respiratory and Allergic Diseases,
大阪はびきの医療センター
ROR:
0443v4r38
OpenAlex ID:
I4405284727
Works
899
Awards
7
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial
2009
·
Tetsuya Mitsudomi
, Satoshi Morita
, et al.
·
The Lancet Oncology
·
4,160
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
2016
·
Eric L. Simpson
, Thomas Bieber
, et al.
·
New England Journal of Medicine
·
2,159
PDF
Targeting Interleukin-6 Signaling in Clinic
2019
·
Sujin Kang
, Toshio Tanaka
, et al.
·
Immunity
·
914
PDF
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis
2021
·
Thomas Bieber
, Eric L. Simpson
, et al.
·
New England Journal of Medicine
·
503
PDF
Genome-wide association study identifies eight new susceptibility loci for atopic dermatitis in the Japanese population
2012
·
Tomomitsu Hirota
, Atsushi Takahashi
, et al.
·
Nature Genetics
·
344
IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome
2020
·
Sujin Kang
, Toshio Tanaka
, et al.
·
Proceedings of the National Academy of Sciences
·
335
Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches
2012
·
Osamu Matsuno
·
Respiratory Research
·
335
Genome-wide association study identifies three new susceptibility loci for adult asthma in the Japanese population
2011
·
Tomomitsu Hirota
, Atsushi Takahashi
, et al.
·
Nature Genetics
·
324
NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: A randomized controlled trial for pharmacogenetics-based therapy
2012
·
Junichi Azuma
, Masako Ohno
, et al.
·
European Journal of Clinical Pharmacology
·
285
PDF
Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G)
2016
·
K. Yamazaki
, M. Nagase
, et al.
·
Annals of Oncology
·
277
Thymic Stromal Lymphopoietin Gene Promoter Polymorphisms Are Associated with Susceptibility to Bronchial Asthma
2010
·
Michishige Harada
, Tomomitsu Hirota
, et al.
·
American Journal of Respiratory Cell and Molecular Biology
·
224
Associations of functional NLRP3 polymorphisms with susceptibility to food-induced anaphylaxis and aspirin-induced asthma
2009
·
Yuki Hitomi
, Motohiro Ebisawa
, et al.
·
Journal of Allergy and Clinical Immunology
·
210
PDF
Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung cancer
2012
·
Seiji Niho
, Hideo Kunitoh
, et al.
·
Lung Cancer
·
206
Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403)
2008
·
K Tamura
, I Okamoto
, et al.
·
British Journal of Cancer
·
203
PDF
Combined Survival Analysis of Prospective Clinical Trials of Gefitinib for Non–Small Cell Lung Cancer with EGFR Mutations
2009
·
Satoshi Morita
, Isamu Okamoto
, et al.
·
Clinical Cancer Research
·
192
Efficacy and safety of dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis: a pooled analysis of two phase 3 randomized trials (LIBERTY AD SOLO 1 and LIBERTY AD SOLO 2)
2019
·
Diamant Thaçi
, Eric L. Simpson
, et al.
·
Journal of Dermatological Science
·
189
PDF
Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: Comparison with 9p21 FISH and BAP1 immunohistochemistry
2016
·
Tomoyuki Hida
, Makoto Hamasaki
, et al.
·
Lung Cancer
·
183
Functional Analysis of the Thymic Stromal Lymphopoietin Variants in Human Bronchial Epithelial Cells
2008
·
Michishige Harada
, Tomomitsu Hirota
, et al.
·
American Journal of Respiratory Cell and Molecular Biology
·
180
Clinical Practice Guidelines for the Management of Atopic Dermatitis 2016
2016
·
Hidehisa Saeki
, Takeshi Nakahara
, et al.
·
The Journal of Dermatology
·
176
Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)
2018
·
J.R. Chalmers
, K.S. Thomas
, et al.
·
British Journal of Dermatology
·
162
PDF
Epithelial to Mesenchymal Transition Is a Determinant of Sensitivity to Chemoradiotherapy in Non-Small Cell Lung Cancer
2011
·
Yasushi Shintani
, Akira Okimura
, et al.
·
The Annals of Thoracic Surgery
·
162
PDF
Thymus and activation‐regulated chemokine as a clinical biomarker in atopic dermatitis
2014
·
Yoko Kataoka
·
The Journal of Dermatology
·
155
Updated overall survival results of WJTOG 3405, a randomized phase III trial comparing gefitinib (G) with cisplatin plus docetaxel (CD) as the first-line treatment for patients with non-small cell lung cancer harboring mutations of the epidermal growth factor receptor (EGFR).
2012
·
Tetsuya Mitsudomi
, Satoshi Morita
, et al.
·
Journal of Clinical Oncology
·
144
Isolation and Expression Profiling of Genes Upregulated in the Peripheral Blood Cells of Systemic Lupus Erythematosus Patients
2005
·
Taeko Ishii
, Hiroaki Onda
, et al.
·
DNA Research
·
140
A phase 3 study of induction treatment with concurrent chemoradiotherapy versus chemotherapy before surgery in patients with pathologically confirmed N2 stage IIIA nonsmall cell lung cancer (WJTOG9903)
2012
·
Nobuyuki Katakami
, Hirohito Tada
, et al.
·
Cancer
·
132
PDF
Show more works
View as search
Works count:
899
Citation count:
47,930
Year
Topic
Type
